Recent Acquisitions TMB has recently finalized the acquisition of key assets by LEO Pharma, signaling potential synergy and co-marketing opportunities in the dermatological field.

Expansion Plan With TMB-001 project aiming to develop a topical treatment for skin diseases, there is a strong potential for partnerships in the pharmaceutical industry to leverage this innovative solution.

Financial Restructuring Following Chapter 11 bankruptcy, opportunities may arise for financial institutions to provide funding or investment options post NYSE American delisting.

Compliance Achievement The NYSE acceptance of TMB's business plan represents an opportunity for stakeholders seeking to engage with a company that is actively working to regain listing compliance and enhance overall financial stability.

Target Market Analysis Despite financial challenges, TMB’s focus on developing treatments for rare and orphan dermatologic diseases opens up opportunities for collaboration with healthcare institutions and research organizations aiming to address unmet medical needs.